Clinical Trial Update: Incretin-based Therapy in Late Preclinical Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial update on incretin-based therapy for late preclinical Type 1 Diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Oulu | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED